Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Naltrexone and Acetaminophen in Chronic Low Back Pain
NCT03201393Phase 2Completed
- Sponsor
- Allodynic Therapeutics
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, acetaminophen in chronic low back pain (CLBP), lumbar radiculopathy, sponsored by Allodynic Therapeutics. Started Aug 2017; status: completed.
02
Drugs
naltrexoneacetaminophen
03
Conditions
chronic low back pain (CLBP)lumbar radiculopathy
Beyond the preview
Go deeper on NCT03201393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201393.